Of the four G protein coupled adenosine receptor (AR) subtypes, the A(
1) is best suited for studies of reconstitution with G proteins. Recom
binant A(1) receptors extended with hexahistidine and FLAG have been p
urified to near homogeneity. In reconstitution assays using pure recom
binant G protein subunits, the composition of the gamma subunit influe
nces coupling to purified A(1)ARs. The least well characterized AR is
the A(2B). New data indicate that A(2B)ARs can trigger the degranulati
on of canine and human mast cell lines. Recombinant human A(2B)ARs are
blocked by the anti-asthma drugs theophylline and enprofylline at con
centrations that are used therapeutically to treat asthma. Although A(
2B)ARs have long been known to stimulate adenylyl cyclase, they also c
an activate phospholipase C and mobilize Ca2+ by signaling through Gq/
11. There is great potential for new therapies based on compounds that
selectively target individual AR subtypes.